InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Cherington Charles, Director. Insider active across 1 companies, notably Brooklyn ImmunoTherapeutics, Inc.. Aggregated, 4 filings have been published. Total volume traded: €5.2m. The latest transaction was disclosed on 1 June 2021 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
092 shares0
Common Stock
SEC:0001140361-21-041286·
092 shares0
Common Stock
SEC:0001140361-21-041286:0·
€3m200,000 shares@ €13.1163100.0% of flow
Common Stock
SEC:0001140361-21-021772·
€3m200,000 shares@ €13.11630.34% mcap50.0% of flow
Common Stock
SEC:0001140361-21-021772:0·
4 of 4 declarations
About Cherington Charles
Charles Cherington is a Director at Brooklyn ImmunoTherapeutics, Inc. He plays a key role in the governance and strategy of the company. Brooklyn ImmunoTherapeutics is a biopharmaceutical company focused on developing immunological treatments. Charles brings valuable expertise in the field, contributing to the company's direction and growth.
